Literature DB >> 19820759

[Study of oxidative stress in advanced kidney disease].

M J Puchades Montesa1, M A González Rico, M A Solís Salguero, I Torregrosa Maicas, M C Tormos Muñoz, G Saez Tormo, I Juan Garcia, A Miguel Carrasco.   

Abstract

INTRODUCTION: Introduction Patients with Chronic renal Disease (CRD) often have cardiovascular disease that is the main cause of morbidity and mortality. Oxidative stress and a subclinical inflammation are crucial factors in its development. The aim of this study was to asses the oxidation of the main molecular lines in patients with advanced renal disease without dialysis and to determinate the best biomarker to asses this stress. PATIENTS AND METHODS: We performed an observational study to measure the most important oxidative biomarkers in 32 patients with stage 4 CRD (MDRD = 22.1 +/- 1.08 ml/min) compared with the values obtained in a control group. In peripheral lymphocytes we measured, the lipid peroxidation by Malondialdehyde (MDA) and F2 Isoprostanes in plasma; protein oxidation by glutathione oxidized/reduced ratio (GSSG/GSH) in peripheral lymphocytes and protein carbonyls in plasma and the oxidative damage in genetic material by modified nucleotide base 8-deoxiguanosina oxo -(8-oxo-dG), after isolating nuclear and mitochondrial DNA. We also studied the antioxidant defenses with superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GSR) and catalase (CAT) in peripheral lymphocytes. We studied the correlation between oxidative stress and the renal function and oxidative stress and co-morbidity factors.
RESULTS: All biomarkers showed important differences in comparison with the control subjects. 821.89 +/- 300.47 ng/ml vs. 270 (95.66) * ng/ml (p < 0.000), MDA 0.11 (0.11) * vs. 0.7 +/- 0.31 nmol/mg prot (p <0.000). GSSG / GSH: 6.89 +/- 1.91 vs. 1.39 +/- 0.75 (p <0.000), protein carbonyls: 7.41 +/- 0.84 vs. 3.63 (1.12) *. Nuclear 8-oxo-dG 7.88 (2.32) vs. 2.96 (1.78) * mitochondrial 8-oxo-dG: 15.73 +/- 2.28 vs. 13.85 +/- 1.44 (p <0.05). The Antioxidant enzymes also showed differences. Nuclear 8-oxo-dG demonstrated an important relationship with the rest of biomarkers, homocysteine (r = 0.305, p <0.05), lipoprotein (a) (r = 0.375, p <0.01), mitochondrial 8-oxo-dG (r = 0.411, p <0.05), GSSH/GSH (r = 0.595, p <0.001) and protein carbonyls (r = 0.489, p <0.05). There was an inverse correlation with total protein (r = -0.247, p <0.01), GSH (r = -0.648, p <0.000), GSR (r = -0.563, p <0.001) and SOD (r = -0.497, p <0.000). We did not find any correlation between these parameters and renal function. The presence of diabetes or the treatment with statins did not showed significant differences. * Median (Interquartile range).
CONCLUSION: There is an important oxidative stress in patients with advanced renal disease, probably established during early stages of disease. Of the studied parameters, the nuclear 8-oxo-dG is the best marker for oxidative stress in CRD.

Entities:  

Mesh:

Year:  2009        PMID: 19820759     DOI: 10.3265/Nefrologia.2009.29.5.5493.en.full

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  9 in total

1.  Reconvene and reconnect the antioxidant hypothesis in human health and disease.

Authors:  P P Singh; Anu Chandra; Farzana Mahdi; Ajanta Roy; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2010-09-03

2.  Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease.

Authors:  J V Calderón-Salinas; E G Muñoz-Reyes; J F Guerrero-Romero; M Rodríguez-Morán; R L Bracho-Riquelme; M A Carrera-Gracia; M A Quintanar-Escorza
Journal:  Mol Cell Biochem       Date:  2011-05-28       Impact factor: 3.396

3.  Cardiovascular Complications in CKD Patients: Role of Oxidative Stress.

Authors:  Elvira O Gosmanova; Ngoc-Anh Le
Journal:  Cardiol Res Pract       Date:  2011-01-02       Impact factor: 1.866

4.  The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study.

Authors:  Bronislaw A Zachara; Jolanta Gromadzinska; Jadwiga Palus; Zbigniew Zbrog; Rafal Swiech; Ewa Twardowska; Wojciech Wasowicz
Journal:  Biol Trace Elem Res       Date:  2010-07-27       Impact factor: 3.738

5.  Apocynin combined with drugs as coadjuvant could be employed to prevent and/or treat the chronic kidney disease.

Authors:  Jorge Osvaldo Montes-Rivera; Feliciano Tamay-Cach; Julio César Quintana-Pérez; Juan Alberto Guevara-Salazar; José Guadalupe Trujillo-Ferrara; Leonardo Del Valle-Mondragón; Mónica Griselda Arellano-Mendoza
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

Review 6.  Plasma Protein Carbonyls as Biomarkers of Oxidative Stress in Chronic Kidney Disease, Dialysis, and Transplantation.

Authors:  Graziano Colombo; Francesco Reggiani; Claudio Angelini; Silvia Finazzi; Emanuela Astori; Maria L Garavaglia; Lucia Landoni; Nicola M Portinaro; Daniela Giustarini; Ranieri Rossi; Annalisa Santucci; Aldo Milzani; Salvatore Badalamenti; Isabella Dalle-Donne
Journal:  Oxid Med Cell Longev       Date:  2020-11-24       Impact factor: 6.543

7.  Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.

Authors:  Angélica Rangel-López; Maria Eugenia Paniagua-Medina; Marcia Urbán-Reyes; Martha Cortes-Arredondo; Cleto Alvarez-Aguilar; Joel López-Meza; Alejandra Ochoa-Zarzosa; Bengt Lindholm; Elvia García-López; José Ramón Paniagua
Journal:  Mutagenesis       Date:  2013-03       Impact factor: 3.000

Review 8.  Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.

Authors:  Alejandra Guillermina Miranda-Díaz; Leonardo Pazarín-Villaseñor; Francisco Gerardo Yanowsky-Escatell; Jorge Andrade-Sierra
Journal:  J Diabetes Res       Date:  2016-07-20       Impact factor: 4.011

Review 9.  Mechanisms of Cardiovascular Disorders in Patients With Chronic Kidney Disease: A Process Related to Accelerated Senescence.

Authors:  Julia Carracedo; Matilde Alique; Carmen Vida; Guillermo Bodega; Noemí Ceprián; Enrique Morales; Manuel Praga; Patricia de Sequera; Rafael Ramírez
Journal:  Front Cell Dev Biol       Date:  2020-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.